Страна: Новая Зеландия
Язык: английский
Источник: Medsafe (Medicines Safety Authority)
Beclometasone dipropionate 50ug (as monohydrate);
Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Beclometasone dipropionate 50 µg (as monohydrate)
50 mcg/dose
Nasal spray suspension
Active: Beclometasone dipropionate 50ug (as monohydrate)
Spray bottle, metered, propylene, 100 dose units
Pharmacy only
Pharmacy only
Farmabios SpA
BECONASE Allergy & Hayfever is indicated for the prophylaxis and treatment of seasonal and perennial allergic rhinitis including hayfever.
Package - Contents - Shelf Life: Spray bottle, metered, propylene - 100 dose units - 24 months from date of manufacture stored at or below 30°C - Spray bottle, metered, propylene - 200 dose units - 24 months from date of manufacture stored at or below 30°C - Spray bottle, metered, glass - 200 dose units - 24 months from date of manufacture stored at or below 30°C
1997-04-01
NEW ZEALAND DATA SHEET 1. PRODUCT NAME BECONASE Allergy & Hayfever nasal spray suspension 50 mcg/dose. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION BECONASE Allergy & Hayfever contains microfine beclometasone dipropionate. Each 100 mg spray delivered by the nasal applicator contains 50 micrograms beclometasone dipropionate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM BECONASE Allergy & Hayfever is a white aqueous suspension delivered by a metering, atomising pump. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS BECONASE Allergy & Hayfever is indicated for the prophylaxis and treatment of seasonal and perennial allergic rhinitis including hayfever. 4.2 DOSE AND METHOD OF ADMINISTRATION BECONASE Allergy & Hayfever is for administration by the intranasal route only. ADULTS AND CHILDREN OVER 12 YEARS OF AGE: The recommended dose is 100 micrograms into each nostril twice daily. Total daily administration should not normally exceed 400 micrograms. Once symptoms are controlled, protection can be maintained at half the dose; one spray into each nostril twice daily. This dose may need to be increased if symptoms worsen. For full therapeutic benefit regular usage is essential. The co-operation of the patient should be sought to comply with the regular dosage schedule and it should be explained that maximum relief may not be obtained within the first few applications. For children under twelve years old, there are insufficient clinical data to recommend use. Do not use for more than six months without obtaining medical advice. 4.3 CONTRAINDICATIONS Hypersensitivity to any component of BECONASE Allergy & Hayfever. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Infections of the nasal passages and paranasal sinuses should be appropriately treated but do not constitute a specific contra-indication to treatment with BECONASE Allergy & Hayfever. Care must be taken while transferring patients from systemic steroid treatment to BECONASE Allergy & Hayfever if there is any reason to suppose that their a Прочитать полный документ